Related Experiment Video
Updated: Mar 18, 2026

Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Cause of death in Chinese Takayasu arteritis patients
Jing Li1, Mengzhu Zhu, Mengtao Li
1Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Key Laboratory of Rheumatology and Clinical Immunology, Beijing Department of Rheumatology, Chinese Medicine Hospital in Linyi City, Linyi, Shandong, China.
Insights
Heart failure is the leading cause of death in Takayasu arteritis (TAK) patients, with secondary hypertension and longer disease duration also increasing mortality risk. Active disease, however, is associated with lower mortality.
Area of Science:
- Rheumatology
- Cardiology
- Internal Medicine
Background:
- Takayasu arteritis (TAK) is a rare, chronic inflammatory disease affecting large arteries, primarily the aorta and its branches.
- Understanding mortality causes and risk factors in TAK is crucial for improving patient outcomes.
- Previous studies have focused on disease prevalence and management, with limited data on specific mortality predictors in Chinese populations.
Purpose of the Study:
- To investigate the causes of death and identify risk factors associated with mortality in hospitalized Takayasu arteritis patients.
- To analyze demographic, clinical, and angiographic data of deceased TAK patients compared to a matched control group.
- To provide insights for better management strategies and long-term prognosis in TAK.
Main Methods:
- Retrospective analysis of medical charts from 12 deceased TAK patients and 40 age- and sex-matched controls admitted between 1983 and 2014.
- Review of demographic data, clinical manifestations, angiographic findings, and direct causes of death by senior rheumatologists.
- Binary logistic regression analysis to identify risk factors for TAK mortality.
Main Results:
- The leading causes of death were heart failure (41.7%), hemorrhage (16.7%), and pulmonary infection (16.7%).
- Deceased patients exhibited longer disease duration, higher prevalence of active disease, secondary hypertension, and congestive heart failure compared to controls.
- Secondary hypertension (OR=9.333), congestive heart failure (OR=5.667), and longer disease duration (OR=1.007) were significant risk factors for mortality, while active disease (OR=0.167) showed a protective association.
Conclusions:
- Heart failure is the primary cause of mortality in TAK patients, followed by ischemia and pulmonary infections.
- Effective management of hypertension and prevention of congestive heart failure are critical for improving long-term survival in TAK.
- While early deaths can occur postoperatively, active disease appears to be associated with a reduced risk of mortality.
Abstract:
To analyze the causes of death and the related risk factors for in-patients with Takayasu arteritis (TAK) admitted to a referral center of China during 1983 to 2014.The medical charts of 12 deceased TAK patients (10 women, 2 men) were reviewed by two senior rheumatologists. The demographic data, clinical manifestations, angiographic presentations, and the direct causes of death were analyzed retrospectively. Medical records of 40 TAK patients (32 women, 8 men) were selected as controls by age and sex matching method from 81 patients who were sampled isometrically from 810 successively admitted TAK in-patients of the same center during the same period. In addition to the comparison of clinical manifestations between the two groups, binary logistic regression was conducted to explore the related risk factors of mortality of TAK.Twelve patients died at the median age of 33.5 (ranging from 13 to 68 years old). The median survival time was 102.5(ranging from 6 to 567) months. The direct causes of death were heart failure in 5 (5/12, 41.7%), hemorrhage in 2 (2/12, 16.7%), pulmonary infection in 2 (2/12, 16.7%), sudden death in 1 (1/12, 8.3%), postoperative complication in 1 (1/12, 8.3%), and end-stage malignancy in 1 (1/12, 8.3%). Ischemia (4/12, 33.3%) and hemorrhage (4/12, 33.3%) were the two most common presentations in deceased patients. Eight patients had received surgical procedures related to TAK changes. Among them, 2 patients died after surgical procedure, the other 6 patients died later of non-operation-related causes. Compared with the control group (n = 40), patients in the deceased group had longer disease duration (P = 0.017), higher proportion of active disease (P = 0.020), secondary hypertension (P = 0.004), and congestive heart failure (P = 0.017). A model of binary logistic regression had revealed that secondary hypertension (odds ratio [OR] = 9.333, 95% confidence interval [CI]: 1.721 - 50.614, P = 0.010), congestive heart failure (OR = 5.667, 95% CI: 1.248 - 25.734, P = 0.025), and longer disease duration (OR = 1.007, 95% CI: 1.001 - 0.735, P = 0.027) were risk factors for TAK mortality. Active disease (OR = 0.167, 95% CI: 0.038 - 50.614, P = 0.018) was negatively associated with death of TAK.Heart failure is the leading cause of death in TAK patients, followed by ischemia and pulmonary infection. Early deaths occur postoperatively but become rare later after the procedure. Well-control of hypertension, and prevention of congestive heart failure may improve the long-term prognosis.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pericarditis III: Medical Management